James McSwiggen

CEO @Mcswiggen Biotech Consulting Llc

Consult with 4-6 companies per month in the areas of sequence design, NGS sequence analysis, data management, patent development and patent due diligence. • Worked with three VC firms to launch new seed companies. One of the companies recently completed a >$80 MM Series B financing round. • Provided scientific due diligence to three clients, leading to the purchase of two targeted companies and the decision not to purchase a third company. • Acted as expert witness in ongoing patent disputes for two biotech companies.